Press/Media

Switch to mobile view »

Press Releases

Fact Sheets

News

Danger in Diaperland: Giardiasis

Press/Media

» Press Releases

Site Map
Press/Media
Legal/Privacy
Report Adverse Event
Contact

Mobile Version
Printer-Friendly Page

Only Tindamax^® is approved to treat both bacterial vaginosis and trichomoniasis (TV).

Clinical Insight

Oral vs vaginal cream therapy: Patient preference for oral dosing is demonstrated to be 84%. More»

Beyond BV

Tindamax^® may be prescribed for other infections including:

The Mission Pharmacal family of products

Learn more about innovative therapies including...

CitraNatal^®Calcium citrate with vital nutrients for mother and baby » Ferralet^® 90The iron therapy with biocomplementary absorption » Urocit^®-KKidney stone therapy with wax-matrix delivery for slow, sustained release »